Bora A - Search Results

1

New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods.

Pacureanu L, Bora A, Crisan L. Pacureanu L, et al. Among authors: bora a. Int J Mol Sci. 2023 May 31;24(11):9583. doi: 10.3390/ijms24119583. Int J Mol Sci. 2023. PMID: 37298535 Free PMC article.

2

PLS-DA - Docking Optimized Combined Energetic Terms (PLSDA-DOCET) protocol: a brief evaluation.

Avram S, Pacureanu LM, Seclaman E, Bora A, Kurunczi L. Avram S, et al. Among authors: bora a. J Chem Inf Model. 2011 Dec 27;51(12):3169-79. doi: 10.1021/ci2002268. Epub 2011 Dec 7. J Chem Inf Model. 2011. PMID: 22066983

3

Retrospective group fusion similarity search based on eROCE evaluation metric.

Avram SI, Crisan L, Bora A, Pacureanu LM, Avram S, Kurunczi L. Avram SI, et al. Among authors: bora a. Bioorg Med Chem. 2013 Mar 1;21(5):1268-78. doi: 10.1016/j.bmc.2012.12.041. Epub 2013 Jan 10. Bioorg Med Chem. 2013. PMID: 23375446

4

PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors.

Crisan L, Pacureanu L, Avram S, Bora A, Avram S, Kurunczi L. Crisan L, et al. Among authors: bora a. J Enzyme Inhib Med Chem. 2014 Aug;29(4):599-610. doi: 10.3109/14756366.2013.833196. Epub 2013 Sep 19. J Enzyme Inhib Med Chem. 2014. PMID: 24047148

5

ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes.

Avram SI, Pacureanu LM, Bora A, Crisan L, Avram S, Kurunczi L. Avram SI, et al. Among authors: bora a. J Chem Inf Model. 2014 Aug 25;54(8):2360-70. doi: 10.1021/ci5002668. Epub 2014 Jul 24. J Chem Inf Model. 2014. PMID: 25026200

6

Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.

Crisan L, Istrate D, Bora A, Pacureanu L. Crisan L, et al. Among authors: bora a. Mol Divers. 2021 Aug;25(3):1775-1794. doi: 10.1007/s11030-020-10155-6. Epub 2020 Nov 25. Mol Divers. 2021. PMID: 33237524

7

Small Molecules of Natural Origin as Potential Anti-HIV Agents: A Computational Approach.

Crisan L, Bora A. Crisan L, et al. Among authors: bora a. Life (Basel). 2021 Jul 20;11(7):722. doi: 10.3390/life11070722. Life (Basel). 2021. PMID: 34357094 Free PMC article.

8

Application of Molecular Docking, Homology Modeling, and Chemometric Approaches to Neonicotinoid Toxicity against Aphis craccivora.

Crisan L, Borota A, Bora A, Suzuki T, Funar-Timofei S. Crisan L, et al. Among authors: bora a. Mol Inform. 2022 Mar;41(3):e2100058. doi: 10.1002/minf.202100058. Epub 2021 Oct 28. Mol Inform. 2022. PMID: 34710288

9

Predictive Models for Fast and Effective Profiling of Kinase Inhibitors.

Bora A, Avram S, Ciucanu I, Raica M, Avram S. Bora A, et al. J Chem Inf Model. 2016 May 23;56(5):895-905. doi: 10.1021/acs.jcim.5b00646. Epub 2016 Apr 26. J Chem Inf Model. 2016. PMID: 27064988

10

Modeling Kinase Inhibition Using Highly Confident Data Sets.

Avram S, Bora A, Halip L, Curpăn R. Avram S, et al. Among authors: bora a. J Chem Inf Model. 2018 May 29;58(5):957-967. doi: 10.1021/acs.jcim.7b00729. Epub 2018 May 9. J Chem Inf Model. 2018. PMID: 29708742

Protein kinases form a consistent class of promising drug targets, and several efforts have been made to predict the activities of small molecules against a representative part of the kinome. This study continues our previous work ( Bora , A. ; Avram , …

Protein kinases form a consistent class of promising drug targets, and several efforts have been made to predict the activities of sm …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page